These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9253980)

  • 1. Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy.
    Chang TC; Huang KM; Hsiao YL; Tzeng SS; Kao SC
    Acta Ophthalmol Scand; 1997 Jun; 75(3):301-4. PubMed ID: 9253980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
    Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
    Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of eye movement to computed tomographic findings in patients with Graves' ophthalmopathy.
    Chen YL; Chang TC; Huang KM; Tzeng SS; Kao SC
    Acta Ophthalmol (Copenh); 1994 Aug; 72(4):472-7. PubMed ID: 7825416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy.
    Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
    Jpn J Ophthalmol; 2002; 46(5):563-7. PubMed ID: 12457917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
    Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
    Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic responses to corticosteroids in Graves' ophthalmopathy.
    Chang TC; Kao SC; Hsiao YL; Lu CP; Huang KM; Tzeng SS
    J Formos Med Assoc; 1996 Nov; 95(11):833-8. PubMed ID: 8990770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
    De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
    Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM
    Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
    Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2005 Apr; 15(4):358-63. PubMed ID: 15876160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters.
    Gerding MN; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2000 May; 52(5):641-6. PubMed ID: 10792345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
    Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy.
    Nagayama Y; Izumi M; Kiriyama T; Yokoyama N; Morita S; Kakezono F; Ohtakara S; Morimoto I; Okamoto S; Nagataki S
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):513-8. PubMed ID: 3321820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.
    Tsujino K; Hirota S; Hagiwara M; Fukada S; Takada Y; Hishikawa Y; Kono M; Abe M
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):857-64. PubMed ID: 11020584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.